help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Avogaro, A.
Right arrow Articles by Pacini, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Avogaro, A.
Right arrow Articles by Pacini, G.
The Journal of Clinical Endocrinology & Metabolism Vol. 87, No. 3 1233-1238
Copyright © 2002 by The Endocrine Society


Other Original Articles

Glucose Tolerance during Moderate Alcohol Intake: Insights on Insulin Action from Glucose/Lactate Dynamics

Angelo Avogaro, Richard M. Watanabe, Lucia Gottardo, Saula de Kreutzenberg, Antonio Tiengo and Giovanni Pacini

Department of Clinical and Experimental Medicine (A.A., L.G., S.d.K., A.T.), University of Padova Medical School, 35128 Padova, Italy; Department of Preventive Medicine (R.M.W.), Keck School of Medicine, University of Southern California, Los Angeles, California 90089; Institute of Systems Science and Biomedical Engineering (G.P.), National Research Council, 35127 Padova, Italy

Address all correspondence and requests for reprints to: Angelo Avogaro, M.D., Dipartimento Medicina Sperimentale, Policlinico, Via Giustiniani 2, 35128 Padova, Italy. E-mail: . angelo.avogaro{at}unipd.it

Abstract

Moderate alcohol (ETOH) intake has been associated with a significant reduction in risk for infarction among general populations. In this study, we assessed the effects of low-dose ETOH (40 g over 3-h period as vodka) on the interaction between glucose (G), insulin, and lactate (L) during the insulin-modified frequently sampled iv glucose tolerance test (FSIGT) (0.3 U/kg body weight between 20–25 min) in eight normal volunteers. In the control (C) study, water was administered. An insulin-independent two-compartment model was used to describe G and L kinetics. Insulin sensitivity (SI) was significantly higher in the ETOH study than in the C study (2.49 ± 0.52 vs. 0.92 ± 0.20 10-4 min-1µU-1ml, C vs. ETOH; P = 0.0391). No significant differences were observed in G effectiveness (0.029 ± 0.004 vs. 0.033 ± 0.004 min-1). Blood L levels were higher during FSIGT when ETOH was administered [area under the curve (AUC), 201 ± 16 vs. 123 ± 23 mmol/liter in 240 min; P = 0.0001]. The dynamic analysis of blood L concentrations showed that ETOH also significantly decreased L clearance (0.0016 ± 0.0011 vs. 0.0029 ± 0.0002 min-1; P = 0.0156), whereas no difference was observed for the fractional conversion of the rate of G disappearance to L (0.0033 ± 0.0012 vs. 0.0031 ± 0.0005 min-1). ETOH decreased baseline plasma FFA concentration; AUC of FFA was markedly reduced with ETOH (65 ± 14 vs. 109 ± 17 mmol/liter in 240 min; P = 0.0063) and inversely correlated with SI (r = 0.693; P = 0.0029). The amount of C-peptide in 240 min as well as the amounts before and after insulin administration were not different between the two tests. We concluded that G and L kinetics derived from FSIGT shows that moderate ETOH intake: 1) improves insulin action; 2) decreases L clearance; and 3) does not affect ß cell function. Because ETOH at moderate doses has a marked antilipolytic action, it might improve insulin action by improving substrate competition. The present findings suggest that moderate alcohol consumption in the diet should not be discouraged.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
M. R. Rickels, A. Naji, and K. L. Teff
Insulin Sensitivity, Glucose Effectiveness, and Free Fatty Acid Dynamics after Human Islet Transplantation for Type 1 Diabetes
J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2138 - 2144.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Brehm, K. Thomaseth, E. Bernroider, P. Nowotny, W. Waldhausl, G. Pacini, and M. Roden
The Role of Endocrine Counterregulation for Estimating Insulin Sensitivity from Intravenous Glucose Tolerance Tests
J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2272 - 2278.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. Avogaro, R. M. Watanabe, A. Dall'Arche, S. Vigili De Kreutzenberg, A. Tiengo, and G. Pacini
Acute Alcohol Consumption Improves Insulin Action Without Affecting Insulin Secretion in Type 2 Diabetic Subjects
Diabetes Care, June 1, 2004; 27(6): 1369 - 1374.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
J. R. Greenfield, K. Samaras, A. B. Jenkins, P. J. Kelly, T. D. Spector, and L. V. Campbell
Moderate Alcohol Consumption, Estrogen Replacement Therapy, and Physical Activity Are Associated With Increased Insulin Sensitivity: Is abdominal adiposity the mediator?
Diabetes Care, October 1, 2003; 26(10): 2734 - 2740.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2002 by The Endocrine Society